Mass Spec
News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
Neurology Blood Tests Primed to Improve Diagnosis, Management of Patients in Alzheimer's and Beyond
Premium
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic mainstream.
The firm's test will be used to aid the detection of cancer in patients with dense breast tissue, which can be more difficult to analyze with mammography alone.
C2N Diagnostics Receives UK Approval for PrecivityAD2 Alzheimer's Blood Test
The UK's Medicines and Healthcare products Regulatory Agency is the first regulatory agency globally to approve PrecivityAD2 as an in vitro diagnostic.
The firm is developing a protein-based lung cancer screening test that also utilizes machine learning.
Top Five Articles on 360Dx Last Week: Delayed Non-Coverage Decisions for Some Genetic Tests; More
Last week, readers were most interested in a story about two Medicare administrative contractors delaying the implementation of a policy not to cover certain genetic tests.